BioSpace News Archive

Deals

Lannett To Report Fiscal 2019 Third-Quarter Financial Results, Host Conference Call On Monday, May 6

Lannett Company, Inc. announced that it will report financial results for its fiscal 2019 third quarter on Monday, May 6, 2019, after the market closes.

April 29, 2019
·
1 min read
Job Trends

Sunflower Health Plan Achieves 98 Percent LTSS Satisfaction Rate

Feedback from Sunflower Health Plan’s members who receive long-term services and supports indicates their satisfaction with their overall care has increased.

April 29, 2019
·
4 min read
Business

HealthSource Salutes Military with Free Care

May is Military Appreciation Month, established to remind Americans of the important role U.S. Armed Forces have played in the history and development of our country.

April 29, 2019
·
3 min read
Deals

Syndax to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 6, 2019

Syndax Pharmaceuticals, Inc. announced that it will release its first quarter 2019 financial results on Monday, May 6, after the close of the U.S. financial markets.

April 29, 2019
·
3 min read
Business

HHAeXchange Announces New Organizational Structure and Executive Appointment of Ken Ernsting

Positions the Company for Long-Term Growth and an Improved Customer Experience

April 29, 2019
·
2 min read
Policy

Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®

Probuphine to be marketed in the European Union under the brand name “Sixmo”

April 29, 2019
·
11 min read
Deals

TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019

Executive Management to Host Conference Call on May 6, 2019 at 4:30 p.m. ET

April 29, 2019
·
4 min read
Acerus Engages Paradigm Capital to Pursue Cannabinoid Opportunities

Acerus Pharmaceuticals Corporation announced that it has engaged Paradigm Capital Inc. as its financial advisor to leverage its proprietary nasal delivery technology in cannabinoid applications through licensing, partnership agreements or other transactions with interested parties.

April 29, 2019
·
3 min read
FDA

AVROBIO, Inc. Announces FDA Clearance of Investigational New Drug Application for AVR-RD-01 Gene Therapy for the Treatment of Fabry Disease

The plato™ platform represents a significant advance towards a commercial-stage gene therapy solution designed to treat thousands of patients

April 29, 2019
·
7 min read
Policy

Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV

If approved, the rilpivirine and cabotegravir regimen would be the first-ever long-acting injectable treatment for adults living with HIV

April 29, 2019
·
12 min read